Walleye Capital LLC Novartis Ag Call Options Transaction History

Walleye Capital LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$106.13 - $120.89 $1.1 Million - $1.26 Million	-10,400 Reduced 10.97%	84,400 $9.71 Million
Q2 2024 Aug 14, 2024	BUY	$92.57 - $107.37 $2.04 Million - $2.36 Million	22,000 Added 30.22%	94,800 $10.1 Million
Q1 2024 May 15, 2024	BUY	$95.27 - $108.47 $504,931 - $574,891	5,300 Added 7.85%	72,800 $7.04 Million
Q4 2023 Feb 14, 2024	SELL	$92.27 - $101.54 $608,982 - $670,164	-6,600 Reduced 8.91%	67,500 $6.82 Million
Q3 2023 Nov 14, 2023	BUY	$94.73 - $105.13 $3.96 Million - $4.39 Million	41,800 Added 129.41%	74,100 $7.55 Million
Q2 2023 Aug 14, 2023	BUY	$92.52 - $104.91 $2.37 Million - $2.69 Million	25,600 Added 382.09%	32,300 $3.26 Million
Q1 2023 May 15, 2023	BUY	$80.03 - $92.81 $536,201 - $621,827	6,700 New	6,700 $616,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $213B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.